(GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=31027912-Month Results From Ongoing Phase 3 Fabry Disease Monotherapy Study Anticipated 3Q13 Phase 2b Pompe Co-Administration Study on Track to Begin... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=309764- Compelling PRIME Data, Calcitriol Manufacturing Submission Highlight Q1- - Company to expand business with DaVita via multi-year supply deal -... ...
http://www.bizwireexpress.com/showstoryGNW.php?storyid=309570Shire (LSE:SHP) Intraday Stock Chart Today : Thursday 2 May 2013 DUBLIN, May 2, 2013 /PRNewswire/ -- Shire delivers 10% increase in Non GAAP... ...
http://in.advfn.com/p.php?pid=nmona&article=57407296First-ever Recognition Marks Milestone for Safety, Quality Standards DENVER DaVita®, a division of DaVita HealthCare Partners Inc. (NYSE: DVA) and... ...
http://www.asianhhm.com/press/pressrelease_archives.asp?PID=3925